Is Feedback plc (FDBK.L) a Buy, Sell, or Hold?
LSE : FDBK.L
Feedback plc
$6.15 GBp
$0 (0.0%)
- Volume
- 40K
- Average Volume
- 57.33K
- Market Capitalization
- $2.69M
- P/E Ratio
- -0.38
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $15.00
- Year Low
- $6.10
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.34
Company Overview
LSE
Thomas James Oakley
Medical - Healthcare Information Services
Healthcare
FDBK.L
29
GB
GBp
Liquidity Metrics
0.00
10.34
10.34
9.56
0.00
Sales & Valuation
$885.62K
3.17
0.60
-0.82
-0.08
Profitability
-$0.25
-$7.32M
-845.25%
-830.62%
-135.17%
-147.74%
P/E Metrics
-0.38
-0.01
-0.01
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
-6.72
3/9
$3.74M
$4.86M
$400K
-$7.6M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Stephen Brown | Regulatory & Compliance Director |
| Emma Jane Stuart | Chief Financial Officer & Director |
| Thomas Spankie | Head of Integration |
| Michael Peter Hayball | Technical Director |
| Mark Fletcher | Managing Director |
| Ben Edrich | Head of Engineering |
| Antoine Saillant | Head of Product |
| Richard Dulcamara | Head of Sales |
| Carrie Goldsworthy | Head of Marketing |
| Thomas James Oakley | Chief Executive Officer & Director |
| Stephen McAteer | Chief Operating Officer |
Poll Results
No votes yet today — be the first to share your view!
About Feedback plc (LSE:FDBK.L) Stock
Feedback plc is a medical technology company, headquartered in London, UK, and established in 1958, that supplies specialized software and systems to individuals and organizations working within the medical imaging sector. Their product portfolio includes TexRAD, a patented software tool designed to extract and quantify textural features within radiological images. This assists research into all types of tumors and helps uncover biomarkers in medical imagery. They also offer TexRAD Lung, a specific software tool used for the clinical analysis of lung cancer within the European Union. Additionally, the company provides the Cadran image platform, a robust picture archiving and communication system (PACS) for hospitals and research institutes, capable of handling images from various imaging m ... odalities like CT and PET scanners. Another key offering is Bleepa, a secure platform for clinical communications that facilitates the safe sharing of high-quality medical images.
Frequently Asked Questions
-
What is the current Feedback plc (FDBK.L) stock price?
-
Feedback plc(LSE:FDBK.L) stock price is $6.15 in the last trading session. During the trading session, FDBK.L stock reached the peak price of $15 while $6.1 was the lowest point it dropped to. The percentage change in FDBK.L stock occurred in the recent session was 0.0% while the dollar amount for the price change in FDBK.L stock was $0.
-
FDBK.L's industry and sector of operation?
-
The LSE listed FDBK.L is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of FDBK.L?
-
Stephen Brown | Regulatory & Compliance Director
Emma Jane Stuart | Chief Financial Officer & Director
Thomas Spankie | Head of Integration
Michael Peter Hayball | Technical Director
Mark Fletcher | Managing Director -
How many employees does FDBK.L have?
-
Number of FDBK.L employees currently stands at 29. FDBK.L operates from 201 Temple Chambers, London, GL EC4Y 0DT, GB.
-
Link for FDBK.L official website?
-
Official Website of FDBK.L is: https://feedbackmedical.com
-
How do I contact FDBK.L?
-
FDBK.L could be contacted at phone #44 20 3997 7634 and can also be accessed through its website. FDBK.L operates from 201 Temple Chambers, London, GL EC4Y 0DT, GB.
-
How many shares of FDBK.L are traded daily?
-
The average number of FDBK.L shares traded daily for last 3 months was 57.33K.
-
What is the market cap of FDBK.L currently?
-
The market value of FDBK.L currently stands at $2.69M with its latest stock price at $6.15